Advanced Biomed
ADVB | NASDAQ
$2.22
-$0.31 (-12.25%)
At close: Nov 16, 2026, 4:00 PM ET
$2.10
-$0.12 (-5.41%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-12.25%
(1D)No price chart data available for 1D timeframe.
Rating
43.5
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #432/1021 (Top 42%)
Key Statistics
Market Data
Market Cap $3.67M
1D Range
2.08 2.49
52W Range
1.90 18.98
Valuation (TTM)
PE -18.50
PB 0.32
EV/EBITDA -0.50
Valuation (NTM)
Forward PE N/A
Forward PEG -0.11
Price Target $0.00
Cash Flow
FCF Yield -21.2%
SBC Adj. FCF Yield -68.5%
SBC Impact -222.9%
Margins
Gross Margin -4619.4%
Operating Margin -5337.5%
FCF Margin -609.5%
Growth (CAGR)
Revenue 3Y | 5Y 150.0% |
100.0%
Dil EPS 3Y | 5Y -4.4% |
123.4%
FCF 3Y | 5Y 17.5% |
-8.1%
Returns
ROA 47.1%
ROE 57.5%
ROIC -60.2%
Financial Health
Net Cash
$214K
Current Ratio 8.09
Interest Coverage -306.20
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Advanced Biomed Inc. functions as an investment holding company, primarily dedicated to the research and development of microfluidic biochip technologies. Based in Taiwan, the company leverages these ...
Sector Healthcare
Industry Medical - Diagnostics & Research
Employees 12
IPO Date Mar 6, 2025
Website www.advb.ai
Fiscal Year July - June
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove ADVB